Novo Nordisk Makes Bold Move in Obesity Market with New Triple Agonist Danish biopharma giant Novo Nordisk is making waves…
Trending
- AI being used more often at point of care, KLAS research shows
- Texas AG investigating Kellogg over ‘unhealthy’ cereal claims
- RFK Jr. will instruct CDC to stop recommending fluoridation
- The years 1992 to 2021 saw decrease in burden of alcohol-related cirrhosis in women
- Kennedy says he plans to tell CDC to stop recommending fluoride in drinking water
- AI helps reduce billing errors, but integration challenges loom
- Reese’s Is Releasing a First-Of-Its-Kind Product Customers Begged For
- Medical cannabis could speed recovery, especially at community recovery homes, pilot study indicates